Market Research Reports and Industry Reports

Alkem Laboratories Ltd (ALKEM) - Financial and Strategic SWOT Analysis Review

  • DESCRIPTION
  • TABLE OF
    CONTENTS
  • RELATED
    REPORTS
  • SAMPLE REQUEST
  • REVIEWS
Alkem Laboratories Ltd (ALKEM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the companys businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the companys key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

- Business description A detailed description of the companys operations and business divisions.
- Corporate strategy Analysts summarization of the companys business strategy.
- SWOT Analysis A detailed analysis of the companys strengths, weakness, opportunities and threats.
- Company history Progression of key events associated with the company.
- Major products and services A list of major products, services and brands of the company.
- Key competitors A list of key competitors to the company.
- Key employees A list of the key executives of the company.
- Executive biographies A brief summary of the executives employment history.
- Key operational heads A list of personnel heading key departments/functions.
- Important locations and subsidiaries A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Alkem Laboratories Ltd (Alkem) is a pharmaceutical company that develops, manufactures and markets generic and specialty pharmaceutical products. The companys products include active pharmaceutical ingredients, generic products, branded products and nutraceuticals. Alkem provides drugs for acute and chronic diseases such as central nervous system disorders, gastro-intestinal infections, diabetes, malaria, pain, cardiovascular diseases and immune disorders. It offers vitamins, minerals and nutrition products. The company distributes its products through a wide network of distributors all over India. It exports products to Europe, Australia, South-East Asia, North America, South America, Russia-CIS and Africa. Alkem is headquartered in Mumbai, Maharashtra, India.

Alkem Laboratories Ltd Key Recent Developments

Jul 14,2017: Update on US FDA inspection for Bioequivalence Facility at Taloja
May 30,2017: 42Gears Solves Alkems Long-standing Problem of Field Device Misuse
May 23,2017: Alkem receives EIR from the US FDA for its Baddi Management Manufacturing Facility
May 17,2017: Alkem Laboratories Announces resignation of Independent Director
Mar 29,2017: Alkem receives EIR from the US FDA for its Alkems Ankaleshwar API Facility

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the companys business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The companys core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company
Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Section 1 - About the Company 5
Alkem Laboratories Ltd - Key Facts 5
Alkem Laboratories Ltd - Key Employees 6
Alkem Laboratories Ltd - Key Employee Biographies 7
Alkem Laboratories Ltd - Major Products and Services 8
Alkem Laboratories Ltd - History 9
Alkem Laboratories Ltd - Company Statement 10
Alkem Laboratories Ltd - Locations And Subsidiaries 11
Head Office 11
Other Locations & Subsidiaries 11
Section 2 Company Analysis 13
Alkem Laboratories Ltd - Business Description 13
Alkem Laboratories Ltd - SWOT Analysis 14
SWOT Analysis - Overview 14
Alkem Laboratories Ltd - Strengths 14
Alkem Laboratories Ltd - Weaknesses 15
Alkem Laboratories Ltd - Opportunities 16
Alkem Laboratories Ltd - Threats 17
Alkem Laboratories Ltd - Key Competitors 18
Section 3 Company Financial Ratios 19
Financial Ratios - Capital Market Ratios 19
Financial Ratios - Annual Ratios 20
Performance Chart 23
Financial Performance 23
Financial Ratios - Interim Ratios 24
Financial Ratios - Ratio Charts 25
Section 4 Companys Lifesciences Financial Deals and Alliances 26
Alkem Laboratories Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 26
Alkem Laboratories Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2011 to YTD 2017 27
Alkem Laboratories Ltd, Recent Deals Summary 28
Section 5 Companys Recent Developments 29
Jul 14, 2017: Update on US FDA inspection for Bioequivalence Facility at Taloja 29
May 23, 2017: Alkem receives EIR from the US FDA for its Baddi Management Manufacturing Facility 30
May 17, 2017: Alkem Laboratories Announces resignation of Independent Director 31
Mar 29, 2017: Alkem receives EIR from the US FDA for its Alkems Ankaleshwar API Facility 32
Mar 10, 2017: Alkem Laboratories Announces Update on US FDA Inspection at Alkem s Baddi Facility 33
Dec 23, 2016: Alkem Receives EIR from the US FDA for its Daman Formulation Facility 34
Dec 23, 2016: Alkem Laboratories Provides Update On Alkems Daman Facility 35
Aug 11, 2016: Successfull US FDA Inspection at Alkems Bioequivalence Facility at Taloja 36
Mar 31, 2016: Alkem Laboratories: UK MHRA Inspection - Update 37
Section 6 Appendix 38
Methodology 38
Ratio Definitions 38
About GlobalData 42
Contact Us 42
Disclaimer 42

List Of Tables


Alkem Laboratories Ltd, Key Facts 5
Alkem Laboratories Ltd, Key Employees 6
Alkem Laboratories Ltd, Key Employee Biographies 7
Alkem Laboratories Ltd, Major Products and Services 8
Alkem Laboratories Ltd, History 9
Alkem Laboratories Ltd, Subsidiaries 11
Alkem Laboratories Ltd, Key Competitors 18
Alkem Laboratories Ltd, Ratios based on current share price 19
Alkem Laboratories Ltd, Annual Ratios 20
Alkem Laboratories Ltd, Annual Ratios (Cont...1) 21
Alkem Laboratories Ltd, Annual Ratios (Cont...2) 22
Alkem Laboratories Ltd, Interim Ratios 24
Alkem Laboratories Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 26
Alkem Laboratories Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2011 to YTD 2017 27
Alkem Laboratories Ltd, Recent Deals Summary 28
Currency Codes 38
Capital Market Ratios 38
Equity Ratios 39
Profitability Ratios 39
Cost Ratios 40
Liquidity Ratios 40
Leverage Ratios 41
Efficiency Ratios 41

List Of Figures


Alkem Laboratories Ltd, Performance Chart (2013 - 2017) 23
Alkem Laboratories Ltd, Ratio Charts 25
Alkem Laboratories Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 26
Alkem Laboratories Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 27

Alkem Laboratories Ltd (ALKEM) - Financial and Strategic SWOT Analysis Review

Alkem Laboratories Ltd (ALKEM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the companys businesses and operations. The profile has been compiled by

USD 125View Report

Alkem Laboratories Ltd Strategic Analysis Review- Alkem Laboratories Ltd SWOT, Outlook, Operations and Financial Profile

Alkem Laboratories Ltd Company Profile provides strategic analysis of Alkem Laboratories Ltd Company in current market conditions. The companys business/ operational/growth strategies are analyzed in the unique research work. Growth

USD 200View Report

Zenotech Laboratories Ltd (532039) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Zenotech Laboratories Ltd (Zenotech) manufactures and markets generic biopharmaceuticals products. It classifies its products into two categories, namely, generic biopharmaceuticals and new biological. The companys Generic biopharmaceuticals is further sub-divided

USD 250View Report

Proteomics International Laboratories Ltd (PIQ) - Medical Equipment - Deals and Alliances Profile

Proteomics International Laboratories Ltd (Proteomics International), a wholly-owned subsidiary and trading name of PILL, is a medical technology company, which focuses on proteomics, the study of structure and function of

USD 250View Report

Fill The Form For Sample Request
Name*
Email*
Mobile No.*
LandLine No.
Country Code.
There is no Reviews available

Delivery Details

PDF FORMAT REPORTS will be delivered by email within 12 to 24 hours after placing the order (Mon-Fri IST)

CHOOSE FORMAT

  • PDF    USD 125
  • Site Licence    USD 250
  • Enterprise Wide Licence    USD 375
$ 125

Reports Details

Published Date : Aug 2017
No. of Pages :42
Country :India
Category :Pharmaceuticals and Healthcare
Publisher :GlobalData
Report Delivery By :Email
Report Delivery Time :12 to 24 hours after placing the order.

Customized Research

If you do not find this specific report suitable to your exact needs then you can also opt for customized research report that will befit all your expectation. To specify your requirements CLICK HERE

 

We Accept

payment
  • fb
  • twitter
  • pinterest
  • linckedin
  • rss
  • youtube